Clincal interpretation of the anti-tuberculosis drug concentrations in diabetic and non-diabetic tuberculosis patients

被引：0
|
作者：
Nilan T Jacob
机构：
[1] Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),
来源：
European Journal of Clinical Pharmacology | 2017年 / 73卷
关键词：
Isoniazid; Tuberculosis Patient; Plasma Drug Concentration; Pyrazinamide; Elevated Blood Glucose;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1049 / 1049
相关论文
共 50 条
  • [31] Drug-Resistant Tuberculosis and Group 5 Anti-Tuberculosis Drugs
    Shokouhi, Shervin
    Darazam, Ilad Alavi
    ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES, 2015, 3 (01):
  • [32] Cutaneous Leukocytoclastic Vasculitis Associated with Pulmonary Tuberculosis and an Anti-tuberculosis Drug
    Tanaka, Yuya
    Kobayashi, Takehiko
    Shimizu, Shigeki
    Kurahara, Yu
    INTERNAL MEDICINE, 2024, 63 (18) : 2587 - 2588
  • [33] Adverse drug reactions of anti-tuberculosis treatment among children with tuberculosis
    Laghari, Madeeha
    Talpur, Bandeh Ali
    Sulaiman, Syed Azhar Syed
    Khan, Amer Hayat
    Bhatti, Zohra
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2020, 9 (03) : 281 - 288
  • [34] Target Identification in Anti-Tuberculosis Drug Discovery
    Capela, Rita
    Felix, Rita
    Clariano, Marta
    Nunes, Diogo
    Perry, Maria de Jesus
    Lopes, Francisca
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (13)
  • [35] New Biomarkers for Predicting Anti-Tuberculosis Drug-Induced Hepatotoxicity in Tunisian Patients with Tuberculosis
    Ben Mahmoud, L.
    Ghozzi, H.
    Hachicha, H.
    Kammoun, A.
    Zalila, N.
    Mahfoudh, N.
    Hammami, S.
    Hakim, A.
    Sahnoun, Z.
    Makni, H.
    Zeghal, Kh
    DRUG SAFETY, 2009, 32 (10) : 908 - 909
  • [36] Patterns of Anti-tuberculosis Drug Resistance among Pulmonary Tuberculosis Patients in Diyala-Iraqi
    Hasan, A. S. H.
    Enaam, A. A.
    Abdul-Wahid, S. S. H.
    MEDICAL SCIENCE, 2014, 6-7 (19-27) : 90 - 95
  • [37] A new concept for anti-tuberculosis drug discovery
    Grzelak, E. M.
    Choules, M.
    Hwang, C. H.
    Nam, J. W.
    Mulugeta, S. G.
    McAlpine, J. B.
    Cai, G.
    Gao, W.
    Lankin, D. C.
    Napolitano, J. G.
    Suh, J. W.
    Yang, S. H.
    Cheng, J.
    Kim, J.
    Cho, S. H.
    Pauli, G. F.
    Franzblau, S. G.
    Jaki, B. U.
    PLANTA MEDICA, 2014, 80 (10) : 759 - 759
  • [38] Oxadiazole scaffolds in anti-tuberculosis drug discovery
    De, Suparna S.
    Khambete, Mihir P.
    Degani, Mariam S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (16) : 1999 - 2007
  • [39] ANTI-TUBERCULOSIS DRUG RESISTANCE IN WEST OF Iran
    Mohajeri, Parviz
    Norozi, Baharak
    Farahani, Abbas
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2014, 43 : 269 - 269
  • [40] FDA approves new anti-tuberculosis drug
    不详
    LEPROSY REVIEW, 1999, 70 (02) : 240 - 240
12345